RT Journal Article
SR Electronic
T1 Evaluating the efficacy of a priming dose of cyclophosphamide prior to pembrolizumab to treat metastatic triple negative breast cancer
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e003427
DO 10.1136/jitc-2021-003427
VO 10
IS 2
A1 Anders, Carey K
A1 Woodcock, Mark G
A1 Van Swearingen, Amanda E D
A1 Moore, Dominic T
A1 Sambade, Maria J
A1 Laurie, Sonia
A1 Robeson, Alexander
A1 Kolupaev, Oleg
A1 Cuaboy, Luz A
A1 Garrett, Amy L
A1 McKinnon, Karen
A1 Cowens, Kristen
A1 Bortone, Dante
A1 Calhoun, Benjamin C
A1 Wilkinson, Alec D
A1 Carey, Lisa
A1 Jolly, Trevor
A1 Muss, Hyman
A1 Reeder-Hayes, Katherine
A1 Kaltman, Rebecca
A1 Jankowitz, Rachel
A1 Gudena, Vinay
A1 Olajide, Oludamilola
A1 Perou, Charles
A1 Dees, E Claire
A1 Vincent, Benjamin G
A1 Serody, Jonathan S
YR 2022
UL http://jitc.bmj.com/content/10/2/e003427.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.